Primary Care Clinics in Randolph, VT Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Gifford Health Care, Inc General Practice Medicare: Medicare Enrolled Practice Location: 44 South Main St., Randolph, VT 05060 Phone: 802-728-7000 Fax: 802-728-4245 |
Gifford Primary Care Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 44 S Main St Ste 2, Randolph, VT 05060 Phone: 802-728-7000 Fax: 802-728-4245 |
Gifford Ob/gyn And Midwifery Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St Ste 1, Randolph, VT 05060 Phone: 802-728-2401 |
Gifford Health Center At Kingwood Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 1422 Route 66 Uppr Level, Randolph, VT 05060 Phone: 802-728-7100 Fax: 802-728-7199 |
Gifford Pedicatric And Adolescent Medicine Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 40 S Main St, Randolph, VT 05060 Phone: 802-728-2420 Fax: 802-728-2111 |
News Archive
Technology motivates older people in nursing homes to exercise
Virtual Reality can get the elderly in nursing homes to be happier about exercising. A new research project from Aalborg University shows that the technology motivates older people in nursing homes to get moving.
PhRMA spends $6.3 million lobbying in fourth quarter, slight increase from year before
The Pharmaceutical Research and Manufacturers of America spent $6.3 million lobbying Congress and other government arms on health care in the fourth quarter of 2009, The Associated Press reports. PhRMA "spent just 2 percent more than the $6.17 million it paid out for lobbying in the year-ago period.
FDA acceptance achieved by Greatbatch Medical thanks to help from Ceram
Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.
Study: HIV-infected women less likely to develop cervical cancer
HIV-infected and uninfected women with normal cervical cytology (Pap test) and a negative test result for oncogenic (tumor inducing) human papillomavirus DNA at study enrollment had a similar risk of cervical precancer and cancer after 5 years of follow-up, according to a study in the July 25 issue of JAMA, a theme issue on HIV/AIDS.
Journal of Clinical Oncology publishes CytRx tamibarotene Phase 2b trial results in APL
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the publication of a case report in the peer-reviewed Journal of Clinical Oncology documenting the use of tamibarotene in the successful treatment of a patient with recurrent advanced-stage acute promyelocytic leukemia.
› Verified 4 days ago